Table 4 Performances of the decision support system for the two patient cohorts and the two examiners
| Â | Â | Examiner 1 | Examiner 2 |
|---|---|---|---|
First cohort (239 women) | Sensitivity | 122/123, 99.2% (95.6–100.0) | 121/123, 98.4% (94.3–99.8) |
Specificity | 88/116, 75.9% (67.0–83.3) | 91/116, 78.5% (69.9–85.5) | |
Accuracy | 210/239, 87.9% (83.0–91.7) | 212/239, 88.7% (84.0–92.4) | |
PPV | 122/150, 81.3% (74.2–87.2) | 121/146, 82.9% (75.8–88.6) | |
NPV | 88/89, 98.9% (93.9–100.0) | 91/93, 97.9% (92.5–99.7) | |
Second cohort (35 women) | Sensitivity | 20/20, 100.0% (83.2–100.0) | 20/20, 100.0% (83.2–100.0) |
Specificity | 12/15, 80.0% (51.9–95.7) | 12/15, 80.0% (51.9–95.7) | |
Accuracy | 32/35, 91.4% (76.9–98.2) | 32/35, 91.4% (76.9–98.2) | |
PPV | 20/23, 86.967% (66.4–97.2) | 20/23, 86.967% (66.4–97.2) | |
NPV | 12/12, 100.0% (74.5–100.0) | 12/12, 100.0% (74.5–100.0) |